IMS Health Holdings Inc

IMS Health — Q1 2015 Earnings Presentation

21 slides from IMS Health's earnings presentation, Apr 24, 2015

  1. Slide 1: IMS Health Q1 2015 Earnings Call

    IMS Health Q1 2015 Earnings Call April 24, 2015 IMS Health Confidential. (c) 2015 IMS Health Incorporated. All Rights Reserved.

  2. Slide 2: Legal

    Legal This presentation should be viewed in conjunction with IMS Health’s Q1 2015 earnings call Safe Harbor Statement This presentation includes “forward-looking statements”, including statements regarding future financial and operating results, especially those set forth under the heading “Full-Yea

  3. Slide 3: 1st Quarter Results

    1st Quarter Results $M Revenue EBITDA +7 0% +7.0% +9 8% +9.8% @ CFx @ CFx $632 $645 $216 $ $217 $ Q1 2015 Q1 2014 Q1 2015 Q1 2014 Note: Dollars are actual foreign exchange rates. CFx is constant currency. EBITDA is “Adjusted EBITDA” as defined in the IMS Health earnings release IMS Health Confidenti

  4. Slide 4: Cegedim - Deal Closed, onto Integration

    Cegedim - Deal Closed, onto Integration Integrated Solutions Focus Areas Reference database Market information Go to market Integrate products  Marketing Compliance Social Media Sales Performance Leverage resources IMS Health Confidential. Do not distribute outside your organization. 4 (c) 2015 IMS

  5. Slide 5: 1st Quarter Offering Revenue

    1st Quarter Offering Revenue Offering 1st Quarter Versus Prior Year Constant $M 2015 2014 Reported Currency Information $354 $381 3.0% (7.0%) Technology Services $278 $264 12.7% 5.3% Total $632 $645 7.0% (2.0%) Note: Dollars are actual foreign exchange rates IMS Health Confidential. Do not distribut

  6. Slide 6: 1st Quarter Geographic Revenue

    1st Quarter Geographic Revenue Geography 1st Quarter Versus Prior Year Constant $M 2015 2014 Reported Currency Developed Markets $522 $532 6.1% (1.8%) Emerging Markets $110 $113 11.2% (2.9%) Total $632 $645 7.0% (2.0%) Note: Dollars are actual foreign exchange rates IMS Health Confidential. Do not d

  7. Slide 7: 1st Quarter EBITDA

    1st Quarter EBITDA 1st Quarter Versus Prior Year Constant $M 2015 2014 Reported Currency Adjusted EBITDA (1) $216 $217 9.8% (0.5%) Adjusted EBITDA 34.2% 33.7% 87 bps 49 bps margin g Note: Dollars are actual foreign exchange rates (1) See reconciliations of non-GAAP items in appendix IMS Health Confi

  8. Slide 8: 1st Quarter P&L

    1st Quarter P&L At reported FX rates $M (except per share data) 2015 2014 Net Income / (Loss) $298 ($24) Diluted Earnings / (Loss) per Share $0.86 ($0.09) Adjusted Net Income (1) $136 $70 Adjusted Diluted Earnings per Share (1) $0.39 $0.24 (1) See reconciliations of non-GAAP items in appendix IMS He

  9. Slide 9: 1st Quarter Balance Sheet Items & Metrics

    1st Quarter Balance Sheet Items & Metrics $M 2015 2014 Cash & Cash Equivalents $639 $390 (1) Principal Balance of Debt (2) $3,969 $3,816 (1) Net Debt $3,330 $3,426 (1) Gross Leverage Ratio 4.5x 4.3x (1) Net Cash (Used in) Provided by $30 ($103) Operating Activities Capital Expenditures and Additions

  10. Slide 10: Cegedim Historical Quarterly Phasing

    Cegedim Historical Quarterly Phasing Average phasing Q2 Q3 Q4 Total Q2 – Q4 2013-2014 Revenue 30% 30% 40% 100% EBITDA 20% 25% 55% 100% IMS Health Confidential. Do not distribute outside your organization. 10 (c) 2015 IMS Health Incorporated. All Rights Reserved.

  11. Slide 11: Foreign Currency Movement Since January 2014

    Foreign Currency Movement Since January 2014 Euro and Yen Euro 0% Yen (10%) ~15% Decline (20%) ~20% Decline Jan Jun Dec Mar 2014 2014 2014 2015 Note: Exchange rates are as of month-end Source: Central Bank of Italy IMS Health Confidential. Do not distribute outside your organization. 11 (c) 2015 IMS

  12. Slide 12: 2nd Quarter Guidance

    2nd Quarter Guidance Revenue Q1 2015 Actual Q2 2015 Guidance (1) Constant Currency Growth 7.0% 25 - 26% Fx Impact (9.0%) (14%) Reported Growth (2.0%) 11 - 12% (2) Adjusted j EBITDA Q1 2015 Actual Q Q2 2015 Guidance (1) Q Constant Currency Growth 9.8% 8 - 9% Fx Impact (10.3%) (14%) Reported Growth (0

  13. Slide 13: Full-Year 2015 Guidance

    Full-Year 2015 Guidance Core IMS IMS w/Acquisition (1) Constant Currency Constant Currency Reported (2) Revenue Growth 5 - 6% 19 - 20% ~10% Adjusted EBITDA 7.5 - 8.5% 13 - 14% ~4% Growth Adjusted Net Income Growth 16 - 19% 20 - 23% 8 - 11% Adjusted Diluted 11 - 14% 15 - 18% 4 - 6% EPS Note: Bold num

  14. Slide 14: Q&A

    Q&A IMS Health Confidential. (c) 2015 IMS Health Incorporated. All Rights Reserved.

  15. Slide 15: Appendix: Non-GAAP Financial Measures

    Appendix: Non-GAAP Financial Measures IMS Health Confidential. (c) 2015 IMS Health Incorporated. All Rights Reserved.

  16. Slide 16: Net Income to Adjusted EBITDA

    Net Income to Adjusted EBITDA Three Months Ended March 31, (in millions) 2015 2014 Net Income (Loss) $ 298 $ (24) B Benefit fi from f income i taxes (240) (13) Other (income) loss, net (4) 17 Interest expense 37 89 Interest income — (2) Depreciation and amortization 96 107 Deferred revenue purchase

  17. Slide 17: Net Income to Adjusted Net Income & Per Share Data

    Net Income to Adjusted Net Income & Per Share Data Three Months Ended March 31, (in millions, except per share data) 2015 2014 Net Income (Loss) $ 298 $ (24) Benefit from income taxes (240) (13) Amortization associated with purchase accounting 62 76 Deferred revenue purchasing accounting adjustments

  18. Slide 18: Unlevered Free Cash Flow

    Unlevered Free Cash Flow Three Months Ended March 31, (in millions) 2015 2014 Net Cash Provided by (Used in) Operating Activities $ 30 $ (103) Capital expenditures (9) (33) Additions to computer software (23) (21) Free Cash Flow $ (2) $ (157) Cash interest payments 30 102 Cash tax Cas a pay payments

  19. Slide 19: Gross Leverage Ratio

    Gross Leverage Ratio (in millions) Gross Debt as of March 31, 2015 $ 3,969 Adj t d EBITDA ffor th Adjusted the year ended d dDDecember b 3131, 2014 878 Less: Adjusted EBITDA for the three months ended March 31, 2014 (217) Add: Adjusted EBITDA for the three months ended March 31, 2015 216 Adjusted EB

  20. Slide 20: Non-GAAP Adjustments By Income Statement Line Items

    Non-GAAP Adjustments By Income Statement Line Items Three Months Ended March 31, (in millions) 2015 2014 Non-GAAP adjustments included in: Operating costs of information, exclusive of depreciation and amortization 1 4 Direct and incremental costs of technology services, exclusive of depreciation 1 3

  21. Slide 21: END

    END IMS Health Confidential. Do not distribute outside your organization. 21 (c) 2015 IMS Health Incorporated. All Rights Reserved.

IMS Health — Q1 2015 Earnings Presentation on 6ix